Small Business Awards 2017

6 CORPORATE VISION / 2017 Small Business Awards , “At Sintetica, we take our obligation to meet the highest standards of business ethics and integrity incredibly seriously, and make meeting those standards the responsibility of all our employees. That is why, when hiring new employees, we look for ‘smart’ people who share our thirst for diversity, our respect for traditions and our aim to be a global leading company. “Fundamentally, our culture of total respect and the focus to the individual person shall be considered as our fundamental heritage. The people are the real stars of our business and the biggest resource we count on to grow and develop the company. Currently we employ 250 people in Europe with an average of 41 years coming from 28 different countries in the world and we work hard to ensure that everyone feels supported and able to give their best every day.” This internal culture is vital to the success of the company, and as such, when discussing what differentiates Sintetica from competitors, marking them out as the best possible option for their partners, Augusto reflects on how the culture of Sintetica and all the strategic choices are firmly based on respect. “Respect is the core value of the company and it permeates across every employee. The concept of respect is divided into three well-defined directions. It is expressed in relation to its employees, enhancing the different characteristics of each one. Whether for work or as an individual, through activities which create a pleasant environment in which to work and express themselves. This same concept is also expressed towards the patients using Sintetica drugs worldwide, providing them with the highest quality products and investing in innovation to imagine the best care solutions for the future. Consequently, it materializes towards its global partners, showing them loyalty, absolute ethics and both operational and development support of advanced go to market strategies. The convergence of these three well-defined areas make up the Sintetica Value Proposition. It is a distinctive and strategic element of their own identity in the wide world panorama of the pharmaceutical industry. Looking to the future, Augusto has a number of exciting plans to grow Sintetica even further and continue to create innovative, pioneering solutions that will change the face of the pharmaceutical market for the better, as he proudly concludes. “Moving forward, at Sintetica hopes to achieve strong returns on the exceptional efforts of our dedicated teams. We have built up our international network and have done most of the legwork to register our products in over 100 different countries, and these efforts are starting bearing fruits and our products are going to launched in many of these countries. “Our 2021 strategy plan, approved by the board, calls for growth driven by “commercial diffusion of innovation”. Thus, with network of partners who share our ‘quality without compromise’ value we should be able to maintain and expand our current innovation driven value proposition significantly over the coming five years. Moreover, one radical innovation in the field of pain relief after surgery is under final stages of development. The potential of this innovation could be disruptive all over the world and could enhance the way pain is managed in hospital and at home after surgery.”